Safety and Immunogenicity of Three Seasonal Inactivated Influenza Vaccines Among Pregnant Women and Antibody Persistence in Their Infants

Overview

Journal Vaccine

Specialty Allergy & Immunology

Date 2020 Jun 24

PMID 32571718

Citations 7

Authors

Flor M Munoz

Shital M Patel

Lisa A Jackson

Geeta K Swamy

Kathryn M Edwards

Sharon E Frey

Carey R Petrie

Eli A Sendra

Wendy A Keitel

Affiliations

Soon will be listed here.

Abstract

Objective: Inactivated influenza virus vaccines (IIVs) are recommended for all pregnant women in the United States. We conducted a prospective, randomized, double blind study of three licensed seasonal trivalent IIVs (IIV3s) to assess their safety and immunogenicity in pregnant women and determine the level and persistence of passively transferred maternal antibody in infants.

Study Design: 139 pregnant women ages 18-39 years and 14-33 weeks' gestation, and 44 non-pregnant women, were randomized 1:1:1 to receive a single intramuscular dose of one of three licensed IIV3s (Agriflu®, Fluzone®, or Fluarix®) prior to the 2010-2011 influenza season. Reactogenicity, adverse events (AEs) and pregnancy outcomes were documented. Serum samples for hemagglutination inhibition (HAI) and neutralization antibody assays were collected prior to and 28 and 180 days after immunization. Maternal sera and cord blood were collected at the time of delivery and sera were obtained from 44 infants at 6 weeks of age.

Results: Pregnant and non-pregnant women experienced similar frequency of injection site (92% and 86%, respectively) and systemic (95% and 87%, respectively) reactions, the majority of which were mild. There were no vaccine-associated maternal or infant serious AEs. Antibody responses to the three vaccine antigens were not different between pregnant and non-pregnant women. The ratios of cord blood (infant) to maternal HAI antibody titers at delivery ranged between 1.1 and 1.7 for each of the vaccine antigens. Influenza antibody concentrations in infants were 70-40% of the birth titer by 6 weeks of age.

Conclusions: The three IIV3s were well tolerated in pregnant women. Antibody responses were comparable in pregnant and non-pregnant women, and after second or third trimester vaccination. Transplacental transfer of maternal antibodies to the infant was efficient. However, antibody titers decline rapidly in the first 6 weeks of life.

Citing Articles

Impact of maternal COVID-19 infection on offspring immunity and maternal-fetal outcomes at different pregnancy stages: a cohort study.

Sun Y, Luo X, Chen N, Xie L, Hu S, Zhou M BMC Pregnancy Childbirth. 2025; 25(1):219.

PMID: 40022096 PMC: 11869480. DOI: 10.1186/s12884-025-07323-7.

Safety and Efficacy of Vaccines During Pregnancy: A Systematic Review.

Chittajallu L, Kaku R, Kondadasula P, Lim J, Zhumabekova A Cureus. 2025; 17(1):e77176.

PMID: 39925513 PMC: 11806401. DOI: 10.7759/cureus.77176.

Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review.

Davies H, Thorley E, Al-Bahadili R, Sutton N, Burt J, Hookham L Vaccine X. 2024; 18:100464.

PMID: 38495929 PMC: 10943481. DOI: 10.1016/j.jvacx.2024.100464.

Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.

Sadarangani M, Soe P, Shulha H, Valiquette L, Vanderkooi O, Kellner J Lancet Infect Dis. 2022; 22(11):1553-1564.

PMID: 35964614 PMC: 9371587. DOI: 10.1016/S1473-3099(22)00426-1.

Functional and structural modifications of influenza antibodies during pregnancy.

Jennewein M, Kosikova M, Noelette F, Radvak P, Boudreau C, Campbell J iScience. 2022; 25(4):104088.

PMID: 35402869 PMC: 8991102. DOI: 10.1016/j.isci.2022.104088.

References

Irving S, Kieke B, Donahue J, Mascola M, Baggs J, DeStefano F . Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol. 2012; 121(1):159-65. DOI: 10.1097/aog.0b013e318279f56f. View

Steinhoff M, Katz J, Englund J, Khatry S, Shrestha L, Kuypers J . Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis. 2017; 17(9):981-989. PMC: 5573632. DOI: 10.1016/S1473-3099(17)30252-9. View

Kharbanda E, Vazquez-Benitez G, Lipkind H, Naleway A, Lee G, Nordin J . Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol. 2013; 122(3):659-67. DOI: 10.1097/AOG.0b013e3182a1118a. View

Madhi S, Cutland C, Kuwanda L, Weinberg A, Hugo A, Jones S . Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014; 371(10):918-31. DOI: 10.1056/NEJMoa1401480. View

Tavares F, Nazareth I, Monegal J, Kolte I, Verstraeten T, Bauchau V . Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine. 2011; 29(37):6358-65. DOI: 10.1016/j.vaccine.2011.04.114. View

Ding H, Black C, Ball S, Donahue S, Izrael D, Williams W . Influenza vaccination coverage among pregnant women--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep. 2014; 63(37):816-21. PMC: 5779455. View

Kahn K, Black C, Ding H, Williams W, Lu P, Parker Fiebelkorn A . Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2018. MMWR Morb Mortal Wkly Rep. 2018; 67(38):1055-1059. PMC: 6188122. DOI: 10.15585/mmwr.mm6738a3. View

Donahue J, Kieke B, King J, Mascola M, Shimabukuro T, DeStefano F . Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15. Vaccine. 2019; 37(44):6673-6681. PMC: 6906603. DOI: 10.1016/j.vaccine.2019.09.035. View

McMillan M, Porritt K, Kralik D, Costi L, Marshall H . Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine. 2015; 33(18):2108-17. DOI: 10.1016/j.vaccine.2015.02.068. View

10.

Lu Y, Jacobson D, Ashworth L, Grand R, Meyer A, McNeal M . Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009; 104(2):444-53. PMC: 3805272. DOI: 10.1038/ajg.2008.120. View

11.

Beigi R, Goldkind S, Jevaji I . Research on vaccines and antimicrobials during pregnancy: challenges and opportunities. Vaccine. 2013; 31(40):4261-3. DOI: 10.1016/j.vaccine.2013.05.060. View

12.

Munoz F . Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol. 2012; 207(3 Suppl):S33-7. DOI: 10.1016/j.ajog.2012.06.072. View

13.

Fell D, Azziz-Baumgartner E, Baker M, Batra M, Beaute J, Beutels P . Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group. Vaccine. 2017; 35(43):5738-5750. PMC: 8274347. DOI: 10.1016/j.vaccine.2017.08.037. View

14.

Nunes M, Madhi S . Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis. Hum Vaccin Immunother. 2017; 14(3):758-766. PMC: 5861794. DOI: 10.1080/21645515.2017.1345385. View

15.

Conlin A, Bukowinski A, Sevick C, DeScisciolo C, Crum-Cianflone N . Safety of the pandemic H1N1 influenza vaccine among pregnant U.S. military women and their newborns. Obstet Gynecol. 2013; 121(3):511-518. DOI: 10.1097/AOG.0b013e318280d64e. View

16.

Kharbanda E, Vazquez-Benitez G, Shi W, Lipkind H, Naleway A, Molitor B . Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink. Am J Obstet Gynecol. 2012; 207(3 Suppl):S47-51. DOI: 10.1016/j.ajog.2012.06.073. View

17.

Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R . A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012; 30(30):4445-52. DOI: 10.1016/j.vaccine.2012.04.081. View

18.

Marshall V, Gruber M . Influenza immunization during pregnancy: US regulatory perspective. Am J Obstet Gynecol. 2012; 207(3 Suppl):S57-62. DOI: 10.1016/j.ajog.2012.06.075. View

19.

Sukumaran L, McCarthy N, Kharbanda E, Weintraub E, Vazquez-Benitez G, McNeil M . Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy. Obstet Gynecol. 2015; 126(5):1069-1074. PMC: 4618722. DOI: 10.1097/AOG.0000000000001066. View

20.

Schlaudecker E, McNeal M, Dodd C, Ranz J, Steinhoff M . Pregnancy modifies the antibody response to trivalent influenza immunization. J Infect Dis. 2012; 206(11):1670-3. DOI: 10.1093/infdis/jis592. View